{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:31:50Z","timestamp":1788305510163,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,11,27]],"date-time":"2011-11-27T00:00:00Z","timestamp":1322352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00403-011-1191-3","type":"journal-article","created":{"date-parts":[[2011,11,26]],"date-time":"2011-11-26T14:38:46Z","timestamp":1322318326000},"page":"325-331","source":"Crossref","is-referenced-by-count":52,"title":["Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease)"],"prefix":"10.1007","volume":"304","author":[{"given":"Luigi","family":"Petramala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Giustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Zinnamosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Cilenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Formicuccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"D\u2019Erasmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Calvieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Letizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,27]]},"reference":[{"key":"1191_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0306-9877(02)00254-2","volume":"59","author":"M Abdel-Wanis","year":"2002","unstructured":"Abdel-Wanis M, Kawahara N (2002) Hypophosphatemic osteomalacia in neurofibromatosis 1: hypotheses for pathogenesis and higher incidence of spinal deformity. Med Hypotheses 59:183\u2013185","journal-title":"Med Hypotheses"},{"key":"1191_CR2","unstructured":"Adami S, Bertoldo F, Brandi ML, Cepollaro C, Filipponi P, Fiore E, Frediani B, Giannini S, Gonnelli S, Isaia GC, Luisetto G, Mannarino E, Marcocci C, Masi L, Mereu C, Migliaccio S, Minisola S, Nuti R, Rini G, Rossini M, Varenna M, Ventura L, Bianchi G, Societ\u00e0 Italiana dell\u2019Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro (2009) Guidelines for the diagnosis, prevention and treatment of osteoporosis. Reumatismo 61:260\u2013284"},{"key":"1191_CR3","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","volume":"373","author":"AR Asthagiri","year":"2009","unstructured":"Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR (2009) Neurofibromatosis type 2. Lancet 373:1974\u20131986","journal-title":"Lancet"},{"key":"1191_CR4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1523-1747.1999.00609.x","volume":"112","author":"RP Atit","year":"1999","unstructured":"Atit RP, Crowe MJ, Greenhalgh DG, Wenstrup RJ, Ratner N (1999) The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts. J Invest Dermatol 112:835\u2013842","journal-title":"J Invest Dermatol"},{"key":"1191_CR5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ng0296-144","volume":"12","author":"G Bollag","year":"1996","unstructured":"Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K (1996) Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 12:144\u2013148","journal-title":"Nat Genet"},{"key":"1191_CR6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymgme.2007.12.004","volume":"94","author":"N Brunetti-Pierri","year":"2008","unstructured":"Brunetti-Pierri N, Doty SB, Hicks J, Phan K, Mendoza-Londono R, Blazo M, Tran A, Carter S, Lewis RA, Plon SE, Phillips WA, O\u2019Brian Smith E, Ellis KJ, Lee B (2008) Generalized metabolic bone disease in neurofibromatosis type I. Mol Genet Metab 94:105\u2013111","journal-title":"Mol Genet Metab"},{"key":"1191_CR7","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.2106\/JBJS.H.00014","volume":"90","author":"TJ Cho","year":"2008","unstructured":"Cho TJ, Seo JB, Lee HR, Yoo WJ, Chung CY, Choi IH (2008) Biologic characteristics of fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1. J Bone Joint Surg Am 90:2735\u20132744","journal-title":"J Bone Joint Surg Am"},{"key":"1191_CR8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01241398-198601000-00015","volume":"6","author":"AH Crawford Jr","year":"1986","unstructured":"Crawford AH Jr, Bagamery N (1986) Osseous manifestations of neurofibromatosis in childhood. J Pediatr Orthop 6:72\u201388","journal-title":"J Pediatr Orthop"},{"key":"1191_CR9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.bpb.0000271310.87997.ae","volume":"27","author":"S Dulai","year":"2007","unstructured":"Dulai S, Briody J, Schindeler A, North KN, Cowell CT, Little DG (2007) Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort. J Pediatr Orthop 27:472\u2013475","journal-title":"J Pediatr Orthop"},{"key":"1191_CR10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2006.10.010","volume":"4","author":"F Elefteriou","year":"2006","unstructured":"Elefteriou F, Benson MD, Sowa H, Starbuck M, Liu X, Ron D, Parada LF, Karsenty G (2006) ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab 4:441\u2013451","journal-title":"Cell Metab"},{"key":"1191_CR11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/jnnp.2010.206532","volume":"10","author":"RE Ferner","year":"2010","unstructured":"Ferner RE (2010) The neurofibromatosis. Pract Neurol 10:82\u201393","journal-title":"Pract Neurol"},{"key":"1191_CR12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/088307380201700802","volume":"17","author":"JM Friedman","year":"2002","unstructured":"Friedman JM (2002) Neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol 17:548\u2013554","journal-title":"J Child Neurol"},{"key":"1191_CR13","doi-asserted-by":"crossref","first-page":"9658","DOI":"10.1073\/pnas.88.21.9658","volume":"88","author":"DH Gutmann","year":"1991","unstructured":"Gutmann DH, Wood DL, Collins FS (1991) Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci USA 88:9658\u20139662","journal-title":"Proc Natl Acad Sci USA"},{"key":"1191_CR14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bone.2010.06.001","volume":"47","author":"E Heerv\u00e4","year":"2010","unstructured":"Heerv\u00e4 E, Alanne MH, Peltonen S, Kuorilehto T, Hentunen T, V\u00e4\u00e4n\u00e4nen K, Peltonen J (2010) Osteoclasts in neurofibromatosis type 1 display enhanced resorption capacity, aberrant morphology, and resistance to serum deprivation. Bone 47:583\u2013590","journal-title":"Bone"},{"issue":"4","key":"1191_CR15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.prp.2004.09.013","volume":"201","author":"B Hermanns-Sachweh","year":"2005","unstructured":"Hermanns-Sachweh B, Senderek J, Alfer J, Klosterhalfen B, B\u00fcttner R, F\u00fczesi L, Weber M (2005) Vascular changes in the periosteum of congenital pseudarthrosis of the tibia. Pathol Res Pract 201(4):305\u2013312","journal-title":"Pathol Res Pract"},{"key":"1191_CR16","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","volume":"111","author":"SM Huson","year":"1988","unstructured":"Huson SM, Harper PS, Compston DA (1988) Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 111:1355\u20131381","journal-title":"Brain"},{"key":"1191_CR17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s001980170032","volume":"12","author":"T Ill\u00e9s","year":"2001","unstructured":"Ill\u00e9s T, Halmai V, de Jonge T, Dubousset J (2001) Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos Int 12:823\u2013827","journal-title":"Osteoporos Int"},{"key":"1191_CR18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","volume":"4","author":"JA Kanis","year":"1994","unstructured":"Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 4:368\u2013381","journal-title":"Osteoporos Int"},{"key":"1191_CR19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jcb.240570318","volume":"57","author":"BY Klein","year":"1995","unstructured":"Klein BY, Rojansky N, Gal I, Shlomai Z, Liebergall M, Ben-Bassat H (1995) Analysis of cell-mediated mineralization in culture of bone-derived embryonic cells with neurofibromatosis. J Cell Biochem 57:530\u2013542","journal-title":"J Cell Biochem"},{"key":"1191_CR20","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/hmg\/7.8.1261","volume":"7","author":"A Klose","year":"1998","unstructured":"Klose A, Ahmadian MR, Schuelke M, Scheffzek K, Hoffmeyer S, Gewies A, Schmitz F, Kaufmann D, Peters H, Wittinghofer A, N\u00fcrnberg P (1998) Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. Hum Mol Genet 7:1261\u20131268","journal-title":"Hum Mol Genet"},{"key":"1191_CR21","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/hmg\/ddm032","volume":"16","author":"M Kolanczyk","year":"2007","unstructured":"Kolanczyk M, Kossler N, K\u00fchnisch J, Lavitas L, Stricker S, Wilkening U, Manjubala I, Fratzl P, Sp\u00f6rle R, Herrmann BG, Parada LF, Kornak U, Mundlos S (2007) Multiple roles for neurofibromin in skeletal development and growth. Hum Mol Genet 16:874\u2013886","journal-title":"Hum Mol Genet"},{"key":"1191_CR22","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMcpc059008","volume":"352","author":"BR Korf","year":"2005","unstructured":"Korf BR, Henson JW, Stemmer-Rachamimov A (2005) Case records of the Massachusetts General Hospital. Case 13\u20132005. A 48-year-old man with weakness of the limbs and multiple tumors of spinal nerves. N Engl J Med 352:1800\u20131808","journal-title":"N Engl J Med"},{"key":"1191_CR23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/39348","volume":"389","author":"M Kretzschmar","year":"1997","unstructured":"Kretzschmar M, Doody J, Massagu\u00e9 J (1997) Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 389:618\u2013622","journal-title":"Nature"},{"key":"1191_CR24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1359\/JBMR.040130","volume":"19","author":"T Kuorilehto","year":"2004","unstructured":"Kuorilehto T, Nissinen M, Koivunen J, Benson MD, Peltonen J (2004) NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos. J Bone Miner Res 19:983\u2013989","journal-title":"J Bone Miner Res"},{"key":"1191_CR25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s00198-004-1801-4","volume":"16","author":"T Kuorilehto","year":"2005","unstructured":"Kuorilehto T, P\u00f6yh\u00f6nen M, Bloigu R, Heikkinen J, V\u00e4\u00e4n\u00e4nen K, Peltonen J (2005) Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int 16:928\u2013936","journal-title":"Osteoporos Int"},{"key":"1191_CR26","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-005-1940-2","volume":"16","author":"M Lammert","year":"2005","unstructured":"Lammert M, Kappler M, Mautner VF, Lammert K, St\u00f6rkel S, Friedman JM, Atkins D (2005) Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int 16:1161\u20131166","journal-title":"Osteoporos Int"},{"key":"1191_CR27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/WCO.0b013e3280895da8","volume":"20","author":"MJ Lee","year":"2007","unstructured":"Lee MJ, Stephenson DA (2007) Recent developments in neurofibromatosis type 1. Curr Opin Neurol 20:135\u2013141","journal-title":"Curr Opin Neurol"},{"key":"1191_CR28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0959-437X(95)90053-5","volume":"5","author":"F McCormick","year":"1995","unstructured":"McCormick F (1995) Ras signaling and NF1. Curr Opin Genet Dev 5:51\u201355","journal-title":"Curr Opin Genet Dev"},{"key":"1191_CR29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1083\/jcb.148.2.333","volume":"148","author":"T Miyazaki","year":"2000","unstructured":"Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma IM, Oda H, Nakamura K, Tanaka S (2000) Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J Cell Biol 148:333\u2013342","journal-title":"J Cell Biol"},{"key":"1191_CR30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1302\/0301-620X.63B3.6790551","volume":"63B","author":"RT Morrissy","year":"1981","unstructured":"Morrissy RT, Riseborough EJ, Hall JE (1981) Congenital pseudarthrosis of the tibia. J Bone Joint Surg Br 63B:367\u2013375","journal-title":"J Bone Joint Surg Br"},{"key":"1191_CR31","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1359\/jbmr.2003.18.7.1198","volume":"18","author":"H Nakamura","year":"2003","unstructured":"Nakamura H, Hirata A, Tsuji T, Yamamoto T (2003) Role of osteoclast extracellular signal-regulated kinase (ERK) in cell survival and maintenance of cell polarity. J Bone Miner Res 18:1198\u20131205","journal-title":"J Bone Miner Res"},{"key":"1191_CR32","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1210\/en.2003-0717","volume":"144","author":"M Nakamura","year":"2003","unstructured":"Nakamura M, Udagawa N, Matsuura S, Mogi M, Nakamura H, Horiuchi H, Saito N, Hiraoka BY, Kobayashi Y, Takaoka K, Ozawa H, Miyazawa H, Takahashi N (2003) Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. Endocrinology 144:5441\u20135449","journal-title":"Endocrinology"},{"key":"1191_CR33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1359\/jbmr.2003.18.5.827","volume":"18","author":"K Nakayama","year":"2003","unstructured":"Nakayama K, Tamura Y, Suzawa M, Harada S, Fukumoto S, Kato M, Miyazono K, Rodan GA, Takeuchi Y, Fujita T (2003) Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells. J Bone Miner Res 18:827\u2013835","journal-title":"J Bone Miner Res"},{"key":"1191_CR34","doi-asserted-by":"crossref","unstructured":"The Consensus Development Panel (1994) National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma, 11\u201313 December 1991. Arch Neurol 51:201\u2013207","DOI":"10.1001\/archneur.1994.00540140115021"},{"key":"1191_CR35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0736-0266(01)00142-5","volume":"20","author":"AA Reed","year":"2002","unstructured":"Reed AA, Joyner CJ, Brownlow HC, Simpson AH (2002) Human atrophic fracture non-unions are not avascular. J Orthop Res 20:593\u2013599","journal-title":"J Orthop Res"},{"key":"1191_CR36","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198112313052704","volume":"305","author":"VM Riccardi","year":"1981","unstructured":"Riccardi VM (1981) Von Recklinghausen neurofibromatosis. N Engl J Med 305:1617\u20131627","journal-title":"N Engl J Med"},{"key":"1191_CR37","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bone.2007.11.006","volume":"42","author":"A Schindeler","year":"2008","unstructured":"Schindeler A, Little DG (2008) Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1). Bone 42:616\u2013622","journal-title":"Bone"},{"key":"1191_CR38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00198-009-0933-y","volume":"21","author":"S Seitz","year":"2010","unstructured":"Seitz S, Schnabel C, Busse B, Schmidt HU, Beil FT, Friedrich RE, Schinke T, Mautner VF, Amling M (2010) High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1. Osteoporos Int 21:119\u2013127","journal-title":"Osteoporos Int"},{"key":"1191_CR39","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/sj.cdd.4402057","volume":"14","author":"S Shapira","year":"2007","unstructured":"Shapira S, Barkan B, Friedman E, Kloog Y, Stein R (2007) The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways. Cell Death Differ 14:895\u2013906","journal-title":"Cell Death Differ"},{"key":"1191_CR40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/504441","volume":"79","author":"DA Stevenson","year":"2006","unstructured":"Stevenson DA, Zhou H, Ashrafi S, Messiaen LM, Carey JC, D\u02bcAstous JL, Santora SD, Viskochil DH (2006) Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet 79:143\u2013148","journal-title":"Am J Hum Genet"},{"key":"1191_CR41","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/088307380201700804","volume":"17","author":"D Viskochil","year":"2002","unstructured":"Viskochil D (2002) Genetics of neurofibromatosis 1 and the NF1 gene. J Child Neurol 17:562\u2013570 discussion 571\u2013572, 646\u2013651","journal-title":"J Child Neurol"},{"key":"1191_CR42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","volume":"12","author":"T Wada","year":"2006","unstructured":"Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12:17\u201325","journal-title":"Trends Mol Med"},{"key":"1191_CR43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02554965","volume":"46","author":"RS Weinstein","year":"1990","unstructured":"Weinstein RS, Harris RL (1990) Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis. Calcif Tissue Int 46:361\u2013366","journal-title":"Calcif Tissue Int"},{"key":"1191_CR44","unstructured":"Writing Group for the ISCD Position Development Conference (2004) Position statement : executive summary. J Clin Densitom 7:7\u201312"},{"key":"1191_CR45","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1172\/JCI29092","volume":"116","author":"FC Yang","year":"2006","unstructured":"Yang FC, Chen S, Robling AG, Yu X, Nebesio TD, Yan J, Morgan T, Li X, Yuan J, Hock J, Ingram DA, Clapp DW (2006) Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions. J Clin Invest 116:2880\u20132891","journal-title":"J Clin Invest"},{"key":"1191_CR46","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/088307380201700812","volume":"17","author":"H Young","year":"2002","unstructured":"Young H, Hyman S, North K (2002) Neurofibromatosis 1: clinical review and exceptions to the rules. J Child Neurol 17:613\u2013621","journal-title":"J Child Neurol"},{"key":"1191_CR47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/excr.2000.5138","volume":"264","author":"Y Zhu","year":"2001","unstructured":"Zhu Y, Parada LF (2001) Neurofibromin, a tumor suppressor in the nervous system. Exp Cell Res 264:19\u201328","journal-title":"Exp Cell Res"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-011-1191-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-011-1191-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-011-1191-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T02:44:19Z","timestamp":1560998659000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-011-1191-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,27]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["1191"],"URL":"https:\/\/doi.org\/10.1007\/s00403-011-1191-3","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,27]]}}}